FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Alvogen Nifedipine Extended-Release Tablets Recall

Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured fo…

Alvogen, Inc · Pine Brook, NJ

Risk level
Class III
Reported by FDA
Apr 12, 2017
Recall ID
D-0630-2017
Check your lot numberHow we source this data

Summary

Alvogen recalled Nifedipine Extended-Release Tablets starting Mar 7, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0630-2017 on Apr 12, 2017. Reason: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib. Status: Terminated.

Why it was recalled

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Product description

Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-369-01.

Lot numbers, UPCs & expiration codes

Lot #: BXH1P41, BXH1BEE1, BXH1BE2, BXH1BE1B, BXH1BE1A, BXH1P41A, Exp. 01/2018; BXH81R1, BXHBD41A, BXH5ZR1, BXH9AL1A, Exp. 06/2018; BXHCUD1A, BXHCUF2A, Exp. 01/2019.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0630-2017
Classification
Class III
Status
Terminated
Recall initiated
Mar 7, 2017
FDA report date
Apr 12, 2017
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Alvogen, Inc

Original FDA data

Every field from FDA enforcement report D-0630-2017, exactly as published.

Show all FDA fields
City
Pine Brook
State
NJ
Status
Terminated
Country
United States
Event ID
76664
Address
10 Bloomfield Ave Bldg B Ste 2
Code information
Lot #: BXH1P41, BXH1BEE1, BXH1BE2, BXH1BE1B, BXH1BE1A, BXH1P41A, Exp. 01/2018; BXH81R1, BXHBD41A, BXH5ZR1, BXH9AL1A, Exp. 06/2018; BXHCUD1A, BXHCUF2A, Exp. 01/2019.
Postal code
07058-9743
Report date
Apr 12, 2017
Product type
Drugs
Recall number
D-0630-2017
Classification
Class III
Recalling firm
Alvogen, Inc
Termination date
Dec 15, 2017
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-369-01.
Distribution pattern
Nationwide
Recall initiation date
Mar 7, 2017
Initial firm notification
Letter
Center classification date
Apr 4, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0630-2017, published Apr 12, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls